Search Results - "Quezada, M. S."

Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis by Gil, M. M., Quezada, M. S., Revello, R., Akolekar, R., Nicolaides, K. H.

“…ABSTRACT Objective To review clinical validation or implementation studies of maternal blood cell‐free (cf) DNA analysis and define the performance of…”
Get full text

Implementation of maternal blood cell‐free DNA testing in early screening for aneuploidies by Gil, M. M., Quezada, M. S., Bregant, B., Ferraro, M., Nicolaides, K. H.

“…ABSTRACT Objective To explore the feasibility of routine maternal blood cell‐free (cf) DNA testing in screening for trisomies 21, 18 and 13 at 10 weeks'…”
Get full text

Screening for trisomies 21, 18 and 13 by cell‐free DNA analysis of maternal blood at 10–11 weeks' gestation and the combined test at 11–13 weeks by Quezada, M. S., Gil, M. M., Francisco, C., Oròsz, G., Nicolaides, K. H.

“…ABSTRACT Objective To examine in a general population the performance of cell‐free DNA (cfDNA) testing for trisomies 21, 18 and 13 at 10–11 weeks' gestation…”
Get full text

Fetal fraction of cell‐free DNA in maternal plasma in the prediction of spontaneous preterm delivery by Quezada, M. S., Francisco, C., Dumitrascu‐Biris, D., Nicolaides, K. H., Poon, L. C.

“…ABSTRACT Objectives To investigate whether, in pregnancies complicated by spontaneous preterm delivery, fetal fraction of cell‐free DNA (cfDNA) in maternal…”
Get full text

Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis by Gil, M M, Akolekar, R, Quezada, M S, Bregant, B, Nicolaides, K H

“…To review clinical validation or implementation studies of maternal blood cell-free (cf) DNA analysis in screening for aneuploidies and to explore the…”
Get more information

Longitudinal change of sFlt‐1/PlGF ratio in singleton pregnancy with early‐onset fetal growth restriction by Herraiz, I., Quezada, M. S., Rodriguez‐Calvo, J., Gómez‐Montes, E., Villalaín, C., Galindo, A.

“…ABSTRACT Objective To describe the evolution of soluble fms‐like tyrosine kinase‐1 to placental growth factor (sFlt‐1/PlGF) ratio in the last 5 weeks prior to…”
Get full text

sFlt‐1/PlGF ratio and timing of delivery in early‐onset fetal growth restriction with antegrade umbilical artery flow by Quezada, M. S., Rodríguez‐Calvo, J., Villalaín, C., Gómez‐Arriaga, P. I., Galindo, A., Herraiz, I.

“…ABSTRACT Objective To analyze the value of the soluble fms‐like tyrosine kinase‐1/placental growth factor (sFlt‐1/PlGF) ratio in predicting the time to…”
Get full text

Prediction of perinatal survival in early‐onset fetal growth restriction: role of placental growth factor by Rodríguez‐Calvo, J., Villalaín, C., Gómez‐Arriaga, P. I., Quezada, M. S., Herraiz, I., Galindo, A.

“…ABSTRACT Objective To analyze the ability to predict perinatal survival and severe neonatal morbidity of cases with early‐onset fetal growth restriction…”
Get full text

Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study by Herraiz, I., Simón, E., Gómez-Arriaga, P.I., Quezada, M.S., García-Burguillo, A., López-Jiménez, E.A., Galindo, A.

“…•sFlt-1/PlGF at 24–28 weeks in high-risk women predicts most early PE/FGR cases.•Optimal diagnostic accuracy was obtained for sFlt-1/PlGF values >95th…”
Get full text

The AGA Equity Project: Where We Are, and Where We Go From Here by Quezada, Sandra M, Carethers, John M, Abreu, Maria, Hendersen, Wendy, Omary, M Bishr, Cryer, Byron

Get full text

EP37.06: Prediction of perinatal survival in early‐onset fetal growth restriction by Villalaín, C., Calvo, J. Rodriguez, Simón, E., Quezada, M.S., Gómez‐Arriaga, P.I., Herraiz, I., Galindo, A.

Get full text

OP10.03: sFlt‐1/PlGF ratio at diagnosis of previable fetal growth restriction and expected time to delivery by Quezada, M.S., Herraiz, I., Villalain, C., Simón, E., Gómez‐Arriaga, P.I., Rodriguez Calvo, J., Galindo, A.

Get full text

OP10.04: Prognostic value of the sFlt‐1/PlGF in stage I early‐onset fetal growth restriction by Villalain Gonzalez, C., Quezada, M.S., Herraiz, I., Rodriguez Calvo, J., Gómez‐Arriaga, P.I., Simón, E., Galindo, A.

Get full text

P06.04: Prognostic factors of vaginal delivery after labour induction of late‐onset fetal growth restriction by Gonzalez, C. Villalain, Herraiz, I., Quezada, M.S., Montes, E. Gómez, Simón, E., Gómez‐Arriaga, P.I., Galindo, A.

Get full text

OP10.04: Mode of delivery on late intrauterine growth‐restricted fetuses: is induction of labour a feasible option? by González‐Villalaín, C., Herraiz, I., Bermejo, R., Quezada, M.S., Reyes, K., Galindo, A.

Get full text

OP16.02: Pulmonary atresia‐critical stenosis with intact ventricular septum: prospective validation of a prenatal score for prediction of postnatal outcome by Gómez Montes, E., Herraiz Garcia, I., Rodriguez Calvo, J., Escribano, D., Quezada, M.S., Gómez‐Arriaga, P.I., Galindo, A.

Get full text

OP12.08: Clinical implementation of the sFlt‐1/PlGF ratio at 24–28 weeks' gestation to detect pre‐eclampsia among high‐risk women selected by risk factors and uterine artery Doppler by Herraiz, I., Gómez‐Arriaga, P.I., Simón, E., García‐Burguillo, A., López‐Jiménez, E.A., Quezada, M.S., Galindo, A.

Get full text

P09.05: Perinatal outcomes on late intrauterine growth‐restricted fetuses: is induction of labour a safe option? by González‐Villalaín, C., Herraiz, I., Gómez‐Arriaga, P.I., Quezada, M.S., Barbero Casado, P., Galindo, A.

Get full text

OP03.02: Elevated uterine arteries resistances at 19–22 and 24–28 weeks' gestation and fetal growth by Batllori, E., Martínez, C., Herraiz, I., Gómez‐Arriaga, P.I., Gómez Montes, E., Quezada, M.S., Galindo, A.

Get full text

OP12.09: Clinical implementation of the sFlt‐1/PlGF ratio at 24–28 weeks' gestation to detect intrauterine growth restriction among high‐risk women selected by risk factors and uterine artery Doppler by Herraiz, I., Simón, E., Gómez‐Arriaga, P.I., Quezada, M.S., García‐Burguillo, A., López‐Jiménez, E.A., Galindo, A.

Get full text